Alpha Teknova, Inc. (NASDAQ:TKNO) Shares Sold by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC decreased its position in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) by 19.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 244,344 shares of the company's stock after selling 60,785 shares during the period. Conestoga Capital Advisors LLC owned 0.46% of Alpha Teknova worth $2,040,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Alpha Teknova in the fourth quarter valued at $94,000. Whalen Wealth Management Inc. acquired a new position in shares of Alpha Teknova during the fourth quarter worth $240,000. Geode Capital Management LLC increased its holdings in shares of Alpha Teknova by 24.4% in the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company's stock valued at $911,000 after acquiring an additional 36,914 shares during the last quarter. State Street Corp raised its holdings in Alpha Teknova by 249.3% during the third quarter. State Street Corp now owns 76,645 shares of the company's stock worth $371,000 after purchasing an additional 54,700 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in Alpha Teknova in the third quarter valued at $1,483,000. Hedge funds and other institutional investors own 13.81% of the company's stock.

Alpha Teknova Stock Performance

TKNO traded down $0.54 during trading on Thursday, hitting $9.22. 160,910 shares of the stock were exchanged, compared to its average volume of 221,863. The stock has a fifty day moving average price of $8.40 and a two-hundred day moving average price of $6.36. Alpha Teknova, Inc. has a 1-year low of $1.15 and a 1-year high of $10.37. The firm has a market capitalization of $491.52 million, a P/E ratio of -12.46 and a beta of 0.34. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.04). The company had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.30 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. During the same quarter in the previous year, the business posted ($0.34) earnings per share. As a group, sell-side analysts predict that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.